CURB vs MPT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CURB exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating deteriorating financial health. The stock is trading at a massive premium ($27.63) compared to its Graham Number ($11.06) and Intrinsic Value ($2.10), with an unsustainable P/E ratio of 92.10. While revenue growth is strong due to acquisitions, earnings have collapsed by nearly 70% YoY, and the dividend payout ratio of 216.67% is fundamentally unsustainable. There is a stark divergence between the bullish analyst consensus and the bearish internal financial data and insider selling.
MPT exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 2/9, indicating weak fundamental health. While the stock trades at a discount to book value (P/B 0.66), this is offset by a catastrophic dividend payout ratio of 1054.55%, which is fundamentally unsustainable. Despite strong top-line revenue growth of 25.4%, the company suffers from negative profit margins and a consistent track record of massive earnings misses. The combination of high debt/equity (2.12) and bearish insider sentiment suggests a high risk of dividend cuts or further capital erosion.
Compare Another Pair
Related Comparisons
CURB vs MPT: Head-to-Head Comparison
This page compares Curbline Properties Corp. (CURB) and Medical Properties Trust, Inc. (MPT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.